Herbert E. Kaufman
Herbert Edward Kaufman | |
---|---|
Born | |
Awards | Weisenfeld and Proctor awards from the Association for Research in Ophthalmology (ARVO)
MAP award from the Society Ophthalmoligica Montgomery Medal from the Irish Ophthalmological Society Pockington Medal from the Royal Society of Ophthalmology Innovators award from the Association of Cataract and Refractive Surgeons |
Scientific career | |
Fields | Ophthalmology |
Institutions |
Herbert Edward Kaufman (September 28, 1931) is an American ophthalmologist who discovered
Scientific career
He began his Princeton University education at age 16, where he graduated Phi Beta Kappa and Magna Cum Laude with a degree in chemistry. This was followed by medical school at Harvard University. Kaufman Graduated in 1956 Magna Cum Laude and Alpha Omega Alpha. He received the New England Pathology Society Award for developing a new type of calcium stain for histological tissue preparation.[1][2]
He performed his Medical Internship at
Toward the end of his work at the NIH, Kaufman was asked to be the first Chairman of the Department of
Research and Discoveries
First Anti-Viral Medication: 5-iododeoxyuridine (IDU)
5-iododeoxyuridine (IDU) had been synthesized 8 years earlier by William Prusoff as an anticancer medication. Kaufman tested IDU as a possible agent to disrupt viral replication in active Herpes Simplex Virus infections of the eye. IDU was proven effective and resulted in the discovery of the first antiviral agent used in humans to treat an active viral infection. This agent was subsequently used to effectively treat Herpes Simplex keratitis, the primary cause of corneal blindness in the Western world at that time.[5] [6] Kaufman also developed the use of
Glaucoma Medication: Timolol
Yale researcher Marvin Sears, observed that
Fungal Corneal Infection Medication: Prymaricin (Natamycin)
While at the University of Florida,
Bandage Contact Lens
With Tony Gasset, Kaufman studied therapeutic soft contact lens (SCL) use to promote corneal healing and reduce pain. They also pioneered the use SCL and collagen shields as a sustained release mechanism for medication to the eye.[10]
Cornea Endothelium Microscopy (Specular Microscopy)
The specular microscope was developed with Bill Bourne, which showed that the human corneal endothelium divided little or not at all. Thus, this tissue must be protected since it could not effectively repair itself like other human tissue. This also led to the discovery that the corneal endothelium was being damaged during cataract surgery as the cataract was removed and the artificial lens was placed into the eye.[11]
Cornea Transplant Tissue storage
Prior to the development of corneal storage media for
There was resistance to this new procedure but with the support of
As eye banks required more time for tissue testing and distribution across the country, Kaufman developed
(k-sol reference) K-sol was used for many years but was removed due to a manufacturing contamination by Taylor Pharmacueticals.[14] Kaufman and Richard Lindstrom, modified the k-sol formulation to make Optisol corneal eye bank storage media in 1992. Optisol remains the most commonly used eye bank preserving medium, according to Kaufman.[15]
Laser Vision Correction
Ultimately, the first human to undergo laser vision correction with the excimer laser was a patient with a uveal melanoma in an eye slated for enucleation who allowed Marguerite McDonald to perform an excimer laser photorefractive keratectomy (PRK). Following enucleation, they performed histologic studies. This was followed by the same work in a series of blind patients who allowed PRK to be performed despite the absence of a benefit to them to forward this technology, which led to the development of LASIK eye surgery.[4] [16] Awards: The Weisenfeld and Proctor awards from the Association for Research in Ophthalmology (ARVO), the MAP award from the Society Ophthalmoligica, The Montgomery Medal from the Irish Ophthalmological Society, The Pockington Medal from the Royal Society of Ophthalmology, 10 outstanding Men of the year by the US Chamber of Commerce, The Innovators award from the Association of Cataract and Refractive Surgeons and others.
He was the editor of Investigative Ophthalmology and Visual Science and served on the Editorial Boards of a number of journals, including the American Journal of Ophthalmology. He has been president of the Association for Research in Vision and Ophthalmology, the Contact Lens Association of Ophthalmologists, and the International Society of Refractive Keratoplasty and has served two terms on the Advisory Council of the National Eye Institute. He has more than 700 publications in his bibliography, including work on herpesvirus and ocular disease, antiviral drugs, corneal surgery, and refractive surgery.[2]
References
- ^ a b "150 Faces of Peddie". 150 Faces of Peddie: 61. Spring 2014.
- ^ a b c d NEOS (1962). "New England Ophthalmological Society Distinguished Achievement Award".
- S2CID 37065768.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ a b c d e f Charters L (March 1, 2018). "Confessions of an Innovator". Ophthalmology Times.
- PMID 14454436.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ Shors T (July 29, 2016). "3.7". Understanding Viruses.
- PMID 14064628.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 322648.
- PMID 4908192.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 5414007.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 1258956.
- PMID 4813700.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 3927738.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^ "FDA Recall #Z-073-9". FDA Enforcement Document. Oct 11–12, 1988.
- PMID 1524127.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 2719572.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link